Technosurg Sales India Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 25-12-2024
- Paid Up Capital ₹ 5.00 M
as on 25-12-2024
- Company Age 8 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 2.75 Cr
as on 25-12-2024
- Revenue 453.52%
(FY 2020)
- Profit 123.65%
(FY 2020)
- Ebitda 370.01%
(FY 2020)
- Net Worth 3.63%
(FY 2020)
- Total Assets -5.38%
(FY 2020)
About Technosurg Sales India
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 5.00 M.
The company has closed loans amounting to ₹2.75 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Rishi Agarwal, Vidhi Agarwal, Ruchi Agarwal, and Three other members serve as directors at the Company.
- CIN/LLPIN
U74999UP2016PTC086831
- Company No.
086831
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 Oct 2016
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Lucknow, Uttar Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Technosurg Sales India?
Board Members(6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rishi Agarwal  | Director | 03-Oct-2016 | Current |
| Vidhi Agarwal | Director | 03-Oct-2016 | Current |
| Ruchi Agarwal | Director | 27-Feb-2018 | Current |
| Maya Agarwal | Director | 27-Feb-2018 | Current |
| Sanjeev Yadav | Director | 10-Feb-2018 | Current |
| Tripti Yadav | Director | 10-Feb-2018 | Current |
Financial Performance of Technosurg Sales India.
Technosurg Sales India Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 453.52% increase. The company also saw a substantial improvement in profitability, with a 123.65% increase in profit. The company's net worth moved up by a moderate rise of 3.63%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Technosurg Sales India?
In 2020, Technosurg Sales India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Technomed Devices India Private LimitedActive 6 years 10 monthsRishi Agarwal and Vidhi Agarwal are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 26 Mar 2018 | ₹2.75 Cr | Satisfied |
How Many Employees Work at Technosurg Sales India?
Unlock and access historical data on people associated with Technosurg Sales India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Technosurg Sales India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Technosurg Sales India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
